ATE430799T1 - Expression von rekombinantem, reifem lysostaphin - Google Patents

Expression von rekombinantem, reifem lysostaphin

Info

Publication number
ATE430799T1
ATE430799T1 AT99974124T AT99974124T ATE430799T1 AT E430799 T1 ATE430799 T1 AT E430799T1 AT 99974124 T AT99974124 T AT 99974124T AT 99974124 T AT99974124 T AT 99974124T AT E430799 T1 ATE430799 T1 AT E430799T1
Authority
AT
Austria
Prior art keywords
lysostaphin
mature lysostaphin
preprolysostaphin
prolysostaphin
mature
Prior art date
Application number
AT99974124T
Other languages
English (en)
Inventor
Ghan Shyam Khatri
Rahul Sharma
Original Assignee
Bharat Biotech International L
Council Of Scient & Ind Res C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Biotech International L, Council Of Scient & Ind Res C filed Critical Bharat Biotech International L
Application granted granted Critical
Publication of ATE430799T1 publication Critical patent/ATE430799T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT99974124T 1999-10-19 1999-10-19 Expression von rekombinantem, reifem lysostaphin ATE430799T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001704 WO2001029201A1 (en) 1999-10-19 1999-10-19 Expression of recombinant mature lysostaphin

Publications (1)

Publication Number Publication Date
ATE430799T1 true ATE430799T1 (de) 2009-05-15

Family

ID=11004914

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99974124T ATE430799T1 (de) 1999-10-19 1999-10-19 Expression von rekombinantem, reifem lysostaphin

Country Status (13)

Country Link
US (1) US6897041B1 (de)
EP (1) EP1224271B1 (de)
JP (1) JP2003512050A (de)
KR (1) KR100635426B1 (de)
CN (1) CN1267551C (de)
AT (1) ATE430799T1 (de)
AU (1) AU784354B2 (de)
BR (1) BR9917526B1 (de)
CA (1) CA2388003C (de)
DE (1) DE69940859D1 (de)
MX (1) MXPA02003885A (de)
NZ (1) NZ518963A (de)
WO (1) WO2001029201A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002367820B2 (en) * 2001-12-21 2007-11-01 Biosynexus Incorporated Truncated lysostaphin molecule with enhanced staphylolytic activity
CN100475965C (zh) * 2005-07-22 2009-04-08 上海高科联合生物技术研发有限公司 一种大肠杆菌高效外分泌表达溶葡萄球菌酶的方法
US20080095756A1 (en) * 2006-09-05 2008-04-24 Biosynexus Incorporated Compositions Comprising Lysostaphin Variants And Methods Of Using The Same
EP2179052B1 (de) * 2007-07-09 2012-11-14 Microsens Medtech Ltd Nachweis von mikroorganismen auf der grundlage ihrer nad-abhängigen dna-ligase-aktivität
WO2009114520A2 (en) * 2008-03-10 2009-09-17 Pharmain Corporation Compositions for treatment with metallopeptidases, methods of making and using the same
US8821860B2 (en) * 2009-08-07 2014-09-02 Lawrence Livermore National Security, Llc Targeted antimicrobials and related compositions, methods and systems
WO2015020765A2 (en) 2013-08-06 2015-02-12 Trustees Of Dartmouth College Unglycosylated lysostaphin variant protein
EP3086805B1 (de) 2013-12-28 2018-10-03 Longhorn Vaccines and Diagnostics, LLC Verwendung von glycyl-glycine endopeptidase zur behandlung von mycobacteria infektionen
KR102195998B1 (ko) * 2019-09-27 2020-12-29 코스맥스 주식회사 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079159A (en) * 1983-12-27 1992-01-07 Genetics Institute, Inc. Method for making tissue plasminogen activator
US4931390A (en) 1986-04-16 1990-06-05 Public Health Research Institute Of The City Of New York, Inc. Expression of the cloned lysostaphin gene
JPH0811074B2 (ja) 1987-10-30 1996-02-07 財団法人化学及血清療法研究所 プレアルブミンをコードする遺伝子を組込んだ組換えプラスミドおよびこれを用いたプレアルブミンの製法
US5122457A (en) * 1989-10-19 1992-06-16 Schering Corporation Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase
US5530100A (en) * 1990-05-07 1996-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods for purification of recombinantly produced proteins
JP2552942B2 (ja) 1990-06-01 1996-11-13 三井東圧化学株式会社 ヒトｂーＦＧＦ受容体遺伝子
US5824528A (en) * 1992-05-01 1998-10-20 Associated Universities, Inc. Cloning and expression of autogenes encoding RNA poly,erases of T7-like bacteriophages
NZ254684A (en) * 1992-08-14 1997-01-29 Commw Scient Ind Res Org Small rna heliothis armigera stunt virus (hasv), related mutants and variants and their use in controlling insect pests
DE4425645A1 (de) * 1994-07-20 1996-02-22 Mueller Karl & Co Kg Deletiertes Lysostaphingen von Staphylococcus simulans
FR2724665B1 (fr) * 1994-09-16 1996-12-20 Rhone Poulenc Rorer Sa Procede de production de proteines recombinantes, plasmides et cellules modifiees
IL118473A0 (en) * 1995-06-02 1996-09-12 Suntory Ltd Staphylococcus aureus V8 protease genes coding therefor and a method for the production thereof
GB9614700D0 (en) * 1996-07-12 1996-09-04 Medical Res Council Over-expression of proteins in E.Coli
CA2211293A1 (en) * 1997-07-23 1999-01-23 Immunova Ltee Recombinant lysostaphin analogs

Also Published As

Publication number Publication date
NZ518963A (en) 2002-11-26
US6897041B1 (en) 2005-05-24
CA2388003C (en) 2013-02-19
AU5995599A (en) 2001-04-30
MXPA02003885A (es) 2005-06-03
CN1406278A (zh) 2003-03-26
KR20020064886A (ko) 2002-08-10
AU784354B2 (en) 2006-03-16
EP1224271A4 (de) 2002-11-27
JP2003512050A (ja) 2003-04-02
DE69940859D1 (de) 2009-06-18
WO2001029201A1 (en) 2001-04-26
BR9917526B1 (pt) 2013-09-24
KR100635426B1 (ko) 2006-10-18
CN1267551C (zh) 2006-08-02
CA2388003A1 (en) 2001-04-26
EP1224271B1 (de) 2009-05-06
EP1224271A1 (de) 2002-07-24
BR9917526A (pt) 2002-06-11

Similar Documents

Publication Publication Date Title
DE69435220D1 (de) Das Natrium Salz des (-)-Enantiomer von Omeprazole
ATE430799T1 (de) Expression von rekombinantem, reifem lysostaphin
ATE254175T1 (de) Mit einem neuen plasmid transformierter e.coli stamm jm83/pkp2 und damit hergestellte phytase
DE69534878D1 (de) Neuartige adenovirale vektoren, verpackungsszellinien, rekombinante adenoviren und verfahren
WO2001087958A3 (en) CRYSTAL STRUCTURE OF WORM NitFhit REVEALS THAT A Nit TETRAMER BINDS TWO Fhit DIMERS
NO972373D0 (no) Vektorer for vevs-spesifikk replikasjon
DE69838676D1 (de) Neuartige phytase
PT1311504E (pt) Tetrazolil-fenil-acetamidas activadoras da glucoquinase
ATE516356T1 (de) Gestutzes lysostaphin-molekül mit verbesserter staphylolytischer wirkung
DK1313762T3 (da) Suppressor-gen
ATE199168T1 (de) Stabilisierung von plasmiden
ATE304371T1 (de) Verwendung von staphylococcus enterotoxin homologe für krebs-therapie
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
ATE345391T1 (de) Hocheffiziente und kontrollierte expression von exogenen genen in e. coli
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
DE69838681D1 (de) Escherichia coli hochexpressionsvektor
IT1208514B (it) Vettori plasmidici ad espressione in escherichia coli e/o bacillussubtilis.
SG148034A1 (en) Non-neurotoxic plasminogen activating factors for treating stroke
ATE529441T1 (de) Expression von proteinen in e.coli
NO995959L (no) DNA-sekvens, vektor, transformerte eukaryote eller prokaryote vertsceller, fremgangsmater for fremstilling av et protein, polypeptid, antistoff, fremgangsmate for isolering og identifisering, farmasoytisk sammensetning og fremgangsmate for screening.
GB0022995D0 (en) Polynucleotide
WO1997031114A3 (en) Polynucleotides and aminoacid sequences from staphylococcus aureus
ES2152315T3 (es) Xamoneline tartrato.
ATE238791T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure als mukolytikum
ATE226446T1 (de) Muteine von wildtyp-cytokinen und ihre verwendung als immunogene

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties